Baseline characteristics and outcome in Romanian patients with Gaucher disease type 1

European Journal of Internal Medicine

Volumn 21, Issue 2, 2010, Pages 104-113

  Grigorescu Sido, Paula ^a   Drugan, Cristina ^a   AlKhzouz, Camelia ^a   Zimmermann, Anca ^b   Coldea, Cristina ^a   Denes, Carmen ^a   Grigorescu, Mircea Dan ^a   Cret, Victoria ^a   Bucerzan, Simona ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Gaucher disease type 1; Imiglucerase; Outcome

Indexed keywords

CHITOTRIOSIDASE; HEMOGLOBIN; IMIGLUCERASE;

ADULT; AGED; ALLELE; ANEMIA; ARTICLE; BONE DENSITY; BONE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME CHEMISTRY; ENZYME REPLACEMENT; FEMALE; GAUCHER DISEASE; GENETIC TRAIT; GENOTYPE; HEALTH STATUS; HUMAN; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PREVALENCE; ROMANIA; SPLENOMEGALY; THROMBOCYTE; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGE OF ONSET; ALLELES; ANEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; GAUCHER DISEASE; GENOTYPE; GLUCOSYLCERAMIDASE; HEXOSAMINIDASES; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; ROMANIA; SPLENOMEGALY; THROMBOCYTOPENIA; YOUNG ADULT;

EID: 77549084320     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2009.11.005     Document Type: Article

References (47)

1. Beutler E., and Grabowski G. Gaucher Disease. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), Mc.Graw-Hill, New York 3635-3668
2. Barnevaeld R.A., Keijzer W., Tegelaers F.P., Ginns E.I., Geurts van Kessel A., Brady R.O., et al. Assignment of the gene coding for human beta-glucocerebrosidase to the region q21-q23 of chromosome 1 using monoclonal antibodies. Hum. Genet. 64 (1983) 227-231
3. Mehta A. Epidemiology and natural history of Gaucher's disease. Eur J Int Med 17 (2006) S2-S5
4. Germain D. La maladie de Gaucher. Hématologie 5 6 (1999) 480-493
5. Stirnemann J, Caubel I, Belmatoug N. La maladie de Gaucher. Encyclopedie Orphanet 2004; http://www.orpha.net/data/patho/FR/fr-gaucher.pdf: 1-5.
6. Meikle P.J., Fuller M., and Hopwood J.J. Epidemiology and screening policy. In: Futerman A.M., and Zimran A. (Eds). Gaucher Disease (2007), CRC Press, Taylor and Francis Group, Fl USA 321-340
7. I.C.G.G: Gaucher Registry. Annual Report 2008.
8. Peters S.P., Coyle P., and Glew R.H. Differenciation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate. Arch Biochem Biophys 175 (1976) 569-582
9. Beutler E., Gelbart T., and West C. The facile detection of the nt 1226 mutation of glucocerebrosidase dose by mismatched PCR. Clin Chim Acta 194 2-3 (1990) 161-166
10. Drugan C., Procopciuc L., Jebeleanu G., Grigorescu-Sido P., Dussau J., Poenaru L., et al. Gaucher disease in Romanian patients: incidence of the most common mutations and phenotypic manifestations. Eur J Hum Genet 10 (2002) 511-515
11. Beutler E., Gelbart T., Kuhl W., Sorhe J., and West C. Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state. Proc Natl Acad Sci USA 88 (1991) 10544-10547
12. Dahl N., Lagerström M., Erikson A., and Pettersson U. Simplified detection of Nci mutation in Gaucher disease. Lancet 335 (1990) 1589-1590
13. Patlas M., Hadas-Halpern I., Abrahamov A., Zimran A., and Elstein D. Repeat abdominal ultrasound evaluation of 100 patients with type I Guacher disease treated with enzyme replacement therapy for up to 7 years. Hematol J 3 (2002) 17-20
14. Weinreb N.J., Charrow J., Andersson H.C., Kaplan P., Kolodny E.H., Mistry P., et al. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J. Med. 113 (2002) 112-119
15. Hollak C.E., van Weely S., van Oers M.H., and Aerts J.M. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J. Clin. Invest 93 3 (1994) 1288-1292
16. Zimran A., Kay A., Gelbart T., Garver P., Thurston D., Saven A., et al. Gaucher disease. Clinical, laboratory, radiologic and genetic features of 53 patients. Medicine 71 (1992) 337-353
17. Simon G., Erdos M., Maródi L., and Tóth J. Gaucher disease: importance of early diagnosis and therapy. Orv Hetil 149 (2008) 743-750
18. Levrat V., Forest I., Fouilhoux A., and Guffon N. Gaucher disease in childhood. Rev Med Intern 28 Suppl 2 (2007) 183-186
19. Kawahara S., Kato A., Oshimi K., and Ida H. Gaucher disease type 1 diagnosed at 63 years old presenting with thrombocytopenia. Rinsho Ketsueki 49 (2008) 335-339
20. Pastores G.M., Weinreb N.J., Aerts H., Andria G., Cox T.M., Giralt M., et al. Therapeutic goals in the treatment of Gaucher disease. Semin Hematol 41 4 Suppl 5 (2004) 4-14
21. Sibille A., Eng C.M., Kim S.J., Pastores G., and Grabowski G.A. Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications. Am J Hum Genet 52 (1993) 1094-1101
22. Fairley C., Zimran A., Philips M., Cizmarik M., Yee J., Weinreb N., et al. Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry. J Inherit Metab Dis 31 (2008) 738-744
23. Haratz D., Manny N., and Raz I. Autoimmune hemolytic anemia in Gaucher's disease. Klin Wochenschr 68 (1990) 94-95
24. Ben Harosh-Katz M., Patlas M., Hadas-Halpern I., Zimran A., and Elstein D. Increased prevalence of cholelithiasis in Gaucher disease: association with splenectomy but not with Gilbert syndrome. J Clin Gastroenterol 38 (2004) 586-589
25. de Fost M., Vom Dahl S., Weverling G.J., Brill N., Brett S., Häussinger D., et al. Increased incidence of cancer in adult Gaucher disease in Western Europe. Blood Cells Mol Dis 36 (2006) 53-58
26. Zimran A., Liphshitz I., Barchana M., Abrahamov A., and Elstein D. Incidence of malignancies among patients with type 1 Gaucher disease from a single referral clinic. Blood Cells Mol Dis 34 (2005) 197-200
27. Landgren O., Turesson I., Gridley G., and Caporaso N.E. Risk of malignant disease among 1525 adult male US Veterans with Gaucher disease. Arch Intern.Med 167 (2007) 1189-1194
28. Rosenbloom B.E., Weinreb N.J., Zimran A., Kacena K.A., Charrow J., and Ward E. Gaucher disease and cancer incidence: a study from the Gaucher Registry. Blood 105 (2005) 4569-4572
29. Grigorescu-Sido P., Drugan C., Creţ V., Al-Khzouz C., Denes C., Coldea C., et al. Outcome of enzyme replacement therapy in patients with Gaucher disease type 1. The Romanian experience. J of Inherit Metab Dis 30 (2007) 783-789
30. Goldblatt J., Szer J., Fletcher J.M., McGill J., Rowell J.A., and Wilson M. Enzyme replacement therapy for Gaucher disease in Australia. Intern Med J 35 3 (2005) 156-161
31. Schaison G., Caubel I., Belmatoug N., Billette de Villemeur T., and Saudubray J.M. French results of enzyme replacement therapy in Gaucher's disease. Bull Acad Natl Med 186 (2002) 851-861
32. Toth J., Szücs F.Z., Benkö K., and Marodi L. Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI. Orv Hetil 144 (2003) 749-755
33. Duan Y.L., Zhang Y.H., Zang Y., Shi H.P., Zhang W.M., and Hu Y.M. A retrospective study on enzyme replacement therapy in patients with Gaucher disease. Zhonghua Er Ke Za Zhi 44 9 (2006) 653-656
34. Chippington S., McHugh K., and Vellodi A. Splenic nodules in paediatric Gaucher disease treated by enzyme replacement therapy. Pediatr Radiol 38 6 (2008) 657-660
35. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21 (2000) 115-137
36. Schiffmann R., Mankin H., Dambrosia J.M., Xavier R.J., Krebs R.J., Hill S.C., et al. Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy. Blood Cells Mol Dis 28 2 (2002) 288-296
37. Ida H., Rennert O.M., Ito T., Maekawa K., and Eto Y. Type 1 Gaucher disease: phenotypic expression and natural history in Japanese patients. Blood Cells Mol Dis 24 1 (1998) 73-81
38. Vom Dahl S., Poll L., Di Rocco M., Ciana G., Denes C., Mariani G., et al. Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients. Curr Med Res Opin 22 6 (2006) 1045-1064
39. Sims K.B., Pastores G.M., Weinreb N.J., Barranger J., Rosenblum B.E., Packman S., et al. Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study. Clin Genet 73 5 (2008) 430-440
40. Wenstrup R.J., Kacena K.A., Kaplan P., Pastores G.M., Prakash-Cheng A., Zimran A., et al. Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease. J Bone Miner Res 22 1 (2007) 119-126
41. de Fost M., Hollak C., Groener A.J.M., Maas M., Poll L.W., et al. Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis. Blood 108 3 (2006) 830-835
42. Maas M., and Poll LW T.M.R. Imaging and quantifying skeletal involvement in Gaucher disease. Br J Radiol 75 Suppl 1 (2002) A13-A24
43. Cox T.M., Aerts J.M., Belmatoug N., Capellini M.D., vom Dahl S., Goldblatt J., et al. Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring. J Inherit Metab Dis 31 3 (2008) 319-336
44. Aerts J.M., and Hollak C.E. Plasma and metabolic abnormalities in Gaucher's disease. Baillieres Clin Haematol 10 (1997) 691-709
45. Weinreb N.J., Aggio M.C., Andersson H.C., Andria G., Charrow J., Clarke J.T., et al. International Collaborative Gaucher Group (ICGG) Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients. Semin Hematol 41 4Suppl5 (2004) 15-22
46. Vellodi A., Foo Y., and Cole T.J. Evaluation of three biochemical markers in the monitoring of Gaucher disease. J Inherit Metab Dis 28 4 (2005) 585-592
47. Boot R.G., Renkema G.H., Verhoek M., Strijland A., Bliek J., de Meulemeester T.M., et al. The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem 273 49 (1998) 25680-25685